RECURRENT ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES

Clinical trials for RECURRENT ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES trials appear

Sign up with your email to follow new studies for RECURRENT ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo attack on stubborn blood cancers

Disease control Ongoing

This study is testing a new combination of two drugs, guadecitabine and atezolizumab, for adults with advanced myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML). It is for patients whose cancer has returned or stopped responding to standard treatments. The …

Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES

Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

RECURRENT ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES

Get alerted when new RECURRENT ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES trials appear

New combo attack on stubborn blood cancers